Letter by Goldstein et al regarding article, "Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromso study"

Comment

Mark R Goldstein et al. Circulation. 2010.

. 2010 Jan 5;121(1):e7; author reply e8.

doi: 10.1161/CIRCULATIONAHA.109.878124.

No abstract available

Comment on

Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø Study, 1994-2001.
Forsdahl SH, Singh K, Solberg S, Jacobsen BK. Forsdahl SH, et al. Circulation. 2009 Apr 28;119(16):2202-8. doi: 10.1161/CIRCULATIONAHA.108.817619. Epub 2009 Apr 13. Circulation. 2009. PMID: 19364978

Letter by Paraskevas regarding article, "Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromso study".
Paraskevas KI. Paraskevas KI. Circulation. 2010 Jan 5;121(1):e6; author reply e8. doi: 10.1161/CIRCULATIONAHA.109.874206. Circulation. 2010. PMID: 20048230 No abstract available.
Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø Study, 1994-2001.
Forsdahl SH, Singh K, Solberg S, Jacobsen BK. Forsdahl SH, et al. Circulation. 2009 Apr 28;119(16):2202-8. doi: 10.1161/CIRCULATIONAHA.108.817619. Epub 2009 Apr 13. Circulation. 2009. PMID: 19364978
Mechanisms of statin-induced myopathy: a role for the ubiquitin-proteasome pathway?
Chapman MJ, Carrie A. Chapman MJ, et al. Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2441-4. doi: 10.1161/10.1161/01.ATV.0000194548.11901.a4. Arterioscler Thromb Vasc Biol. 2005. PMID: 16306434 No abstract available.
New understanding about calcific aortic stenosis and opportunities for pharmacologic intervention.
Moura LM, Maganti K, Puthumana JJ, Rocha-Gonçalves F, Rajamannan NM. Moura LM, et al. Curr Opin Cardiol. 2007 Nov;22(6):572-7. doi: 10.1097/HCO.0b013e3282f0dae6. Curr Opin Cardiol. 2007. PMID: 17921746 Review.
[Hyperlipidemia: decreasing lipid values and effects of statins].
Mathes P. Mathes P. Z Kardiol. 2002;91 Suppl 2:25-9. Z Kardiol. 2002. PMID: 12436762 Review. German. No abstract available.